CHMA Market Cap History



Below is a table of the CHMA market cap history going back to 7/16/2015:

Date CHMA Market Cap
7/16/2015439.39M
8/25/2015558.05M
11/12/2015534.27M
3/8/2016248.09M
5/9/201673.88M
8/5/201671.37M
11/4/201652.37M
3/9/201739.58M
5/2/201737.76M
8/7/201736.54M
11/6/201749.98M
3/8/201840.23M
5/7/201835.36M
8/6/201834.14M
11/5/2018100.17M
3/1/2019106.91M
5/3/2019192.83M
8/2/2019211.86M
10/31/2019220.17M
3/9/2020190.15M
5/4/2020221.05M
8/5/2020273.40M
11/2/2020215.61M
2/26/2021225.01M
4/30/2021172.52M

Also see: CHMA Shares Outstanding History
and CHMA YTD Return
CHMA Historical Market Cap:
-14.90% CAGR
CHMA Historical Market Cap: +-14.90% CAGR

Mouse over chart for data details
7/16/2015 ...4/30/2021
Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with their existing treatments for disease. Employing its Transient Permeability Enhancer technology platform, Co. seeks to develop oral medications that are available as injections. Co.'s MYCAPSSA® (octreotide capsules) for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. MYCAPSSA is an oral somatostatin analog. Co. is focused on the commercialization of MYCAPSSA for the treatment of patients with acromegaly in the U.S. and develops and seeks regulatory approval of MYCAPSSA in the European Union. We show 25 historical shares outstanding datapoints in our CHMA shares outstanding history coverage, used to compute CHMA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CHMA market cap history over the course of time is important for investors interested in comparing CHMA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CHMA versus a peer is one thing; comparing CHMA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CHMA can fluctuate over the course of history. With this page we aim to empower investors researching CHMA by allowing them to research the CHMA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree CHMA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Chiasma (CHMA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CHRS Market Cap History
CI Market Cap History
CINC Market Cap History
CING Market Cap History
CKPT Market Cap History
CLBS Market Cap History
CLDX Market Cap History
CLNN Market Cap History
CLOV Market Cap History
CLPT Market Cap History
More Healthcare companies »

 

CHMA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.